Logo image of SLBEN.LS

SPORT LISBOA E BENFICA-FUT S (SLBEN.LS) Stock Fundamental Analysis

ELI:SLBEN - Euronext Lisbon - PTSLB0AM0010 - Common Stock - Currency: EUR

5  -0.06 (-1.19%)

Fundamental Rating

2

SLBEN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 44 industry peers in the Entertainment industry. There are concerns on the financial health of SLBEN while its profitability can be described as average. SLBEN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

SLBEN had negative earnings in the past year.
SLBEN had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SLBEN reported negative net income in multiple years.
SLBEN had a negative operating cash flow in each of the past 5 years.
SLBEN.LS Yearly Net Income VS EBIT VS OCF VS FCFSLBEN.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

SLBEN's Return On Assets of 6.21% is fine compared to the rest of the industry. SLBEN outperforms 79.55% of its industry peers.
The Return On Equity of SLBEN (27.11%) is better than 86.36% of its industry peers.
SLBEN has a better Return On Invested Capital (10.43%) than 84.09% of its industry peers.
Industry RankSector Rank
ROA 6.21%
ROE 27.11%
ROIC 10.43%
ROA(3y)-3.78%
ROA(5y)-1.22%
ROE(3y)-22.24%
ROE(5y)-10.58%
ROIC(3y)N/A
ROIC(5y)N/A
SLBEN.LS Yearly ROA, ROE, ROICSLBEN.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800 1K

1.3 Margins

SLBEN's Profit Margin of 18.66% is amongst the best of the industry. SLBEN outperforms 88.64% of its industry peers.
SLBEN has a better Operating Margin (26.95%) than 95.45% of its industry peers.
SLBEN's Gross Margin of 53.73% is in line compared to the rest of the industry. SLBEN outperforms 47.73% of its industry peers.
In the last couple of years the Gross Margin of SLBEN has declined.
Industry RankSector Rank
OM 26.95%
PM (TTM) 18.66%
GM 53.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.54%
GM growth 5Y-3.82%
SLBEN.LS Yearly Profit, Operating, Gross MarginsSLBEN.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

SLBEN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SLBEN has about the same amount of shares outstanding.
The number of shares outstanding for SLBEN remains at a similar level compared to 5 years ago.
The debt/assets ratio for SLBEN is higher compared to a year ago.
SLBEN.LS Yearly Shares OutstandingSLBEN.LS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SLBEN.LS Yearly Total Debt VS Total AssetsSLBEN.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 0.57, we must say that SLBEN is in the distress zone and has some risk of bankruptcy.
SLBEN has a Altman-Z score of 0.57. This is in the lower half of the industry: SLBEN underperforms 63.64% of its industry peers.
A Debt/Equity ratio of 1.16 is on the high side and indicates that SLBEN has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.16, SLBEN is doing worse than 61.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Altman-Z 0.57
ROIC/WACC1.71
WACC6.09%
SLBEN.LS Yearly LT Debt VS Equity VS FCFSLBEN.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 0.42 indicates that SLBEN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.42, SLBEN is doing worse than 86.36% of the companies in the same industry.
SLBEN has a Quick Ratio of 0.42. This is a bad value and indicates that SLBEN is not financially healthy enough and could expect problems in meeting its short term obligations.
SLBEN has a worse Quick ratio (0.42) than 84.09% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.42
SLBEN.LS Yearly Current Assets VS Current LiabilitesSLBEN.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for SLBEN have decreased strongly by -844.27% in the last year.
The Revenue has decreased by -8.56% in the past year.
The Revenue has been growing slightly by 4.24% on average over the past years.
EPS 1Y (TTM)-844.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-381.43%
Revenue 1Y (TTM)-8.56%
Revenue growth 3Y23.95%
Revenue growth 5Y4.24%
Sales Q2Q%-13.8%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SLBEN.LS Yearly Revenue VS EstimatesSLBEN.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SLBEN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLBEN.LS Price Earnings VS Forward Price EarningsSLBEN.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLBEN.LS Per share dataSLBEN.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SLBEN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPORT LISBOA E BENFICA-FUT S

ELI:SLBEN (6/20/2025, 7:00:00 PM)

5

-0.06 (-1.19%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners19.7%
Ins Owner ChangeN/A
Market Cap115.00M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF N/A
P/B 0.88
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.36
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-6.85
FCFYN/A
OCF(TTM)-2.52
OCFYN/A
SpS8.29
BVpS5.71
TBVpS-2.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.21%
ROE 27.11%
ROCE 14.3%
ROIC 10.43%
ROICexc 10.45%
ROICexgc 20.06%
OM 26.95%
PM (TTM) 18.66%
GM 53.73%
FCFM N/A
ROA(3y)-3.78%
ROA(5y)-1.22%
ROE(3y)-22.24%
ROE(5y)-10.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.54%
GM growth 5Y-3.82%
F-Score4
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 52.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.42
Altman-Z 0.57
F-Score4
WACC6.09%
ROIC/WACC1.71
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)42.64%
Cap/Sales(5y)52.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-844.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-381.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.56%
Revenue growth 3Y23.95%
Revenue growth 5Y4.24%
Sales Q2Q%-13.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y965.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-46.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.63%
OCF growth 3YN/A
OCF growth 5YN/A